117 related articles for article (PubMed ID: 15013482)
21. Preparation and bioevaluation of 99mTc-carbonyl complex of 5-hydroxy tryptamine derivative.
Satpati D; Bapat K; Mukherjee A; Banerjee S; Kothari K; Venkatesh M
Appl Radiat Isot; 2006 Aug; 64(8):888-92. PubMed ID: 16632373
[TBL] [Abstract][Full Text] [Related]
22. Selective binding of 2-[125I]iodo-nisoxetine to norepinephrine transporters in the brain.
Kung MP; Choi SR; Hou C; Zhuang ZP; Foulon C; Kung HF
Nucl Med Biol; 2004 Jul; 31(5):533-41. PubMed ID: 15219270
[TBL] [Abstract][Full Text] [Related]
23. Pegylated Arg-Gly-Asp peptide: 64Cu labeling and PET imaging of brain tumor alphavbeta3-integrin expression.
Chen X; Hou Y; Tohme M; Park R; Khankaldyyan V; Gonzales-Gomez I; Bading JR; Laug WE; Conti PS
J Nucl Med; 2004 Oct; 45(10):1776-83. PubMed ID: 15471848
[TBL] [Abstract][Full Text] [Related]
24. Synthesis and biological evaluation of (E)-3-styrylpyridine derivatives as amyloid imaging agents for Alzheimer's disease.
Ono M; Haratake M; Nakayama M; Kaneko Y; Kawabata K; Mori H; Kung MP; Kung HF
Nucl Med Biol; 2005 May; 32(4):329-35. PubMed ID: 15878502
[TBL] [Abstract][Full Text] [Related]
25. Localization of adenosine A2A-receptors in rat brain with [3H]ZM-241385.
DeMet EM; Chicz-DeMet A
Naunyn Schmiedebergs Arch Pharmacol; 2002 Nov; 366(5):478-81. PubMed ID: 12382078
[TBL] [Abstract][Full Text] [Related]
26. 11C-labeled KF18446: a potential central nervous system adenosine A2a receptor ligand.
Ishiwata K; Noguchi J; Wakabayashi S; Shimada J; Ogi N; Nariai T; Tanaka A; Endo K; Suzuki F; Senda M
J Nucl Med; 2000 Feb; 41(2):345-54. PubMed ID: 10688121
[TBL] [Abstract][Full Text] [Related]
27. Synthesis and evaluation of radiolabeled analogs of the antidepressant drug zimelidine as potential SPECT-ligands for the serotonin transporter.
Eersels JL; Klok RP; Verbeek J; Jonker AJ; Herscheid JD
Nucl Med Biol; 2004 Jul; 31(5):563-9. PubMed ID: 15219273
[TBL] [Abstract][Full Text] [Related]
28. Synthesis and evaluation of dopamine D3 receptor antagonist 11C-GR218231 as PET tracer for P-glycoprotein.
de Vries EF; Kortekaas R; van Waarde A; Dijkstra D; Elsinga PH; Vaalburg W
J Nucl Med; 2005 Aug; 46(8):1384-92. PubMed ID: 16085598
[TBL] [Abstract][Full Text] [Related]
29. Preclinical studies on [11C]TMSX for mapping adenosine A2A receptors by positron emission tomography.
Ishiwata K; Wang WF; Kimura Y; Kawamura K; Ishii K
Ann Nucl Med; 2003 May; 17(3):205-11. PubMed ID: 12846542
[TBL] [Abstract][Full Text] [Related]
30. Synthesis and biodistribution of radiolabeled alpha 7 nicotinic acetylcholine receptor ligands.
Pomper MG; Phillips E; Fan H; McCarthy DJ; Keith RA; Gordon JC; Scheffel U; Dannals RF; Musachio JL
J Nucl Med; 2005 Feb; 46(2):326-34. PubMed ID: 15695794
[TBL] [Abstract][Full Text] [Related]
31. Evaluation of radioiodinated (-)-o-iodovesamicol as a radiotracer for mapping the vesicular acetylcholine transporter.
Shiba K; Mori H; Tonami N
Ann Nucl Med; 2003 Sep; 17(6):451-6. PubMed ID: 14575378
[TBL] [Abstract][Full Text] [Related]
32. Synthesis and evaluation of nicotine alpha4beta2 receptor radioligand, 5-(3'-18F-fluoropropyl)-3-(2-(S)-pyrrolidinylmethoxy)pyridine, in rodents and PET in nonhuman primate.
Chattopadhyay S; Xue B; Collins D; Pichika R; Bagnera R; Leslie FM; Christian BT; Shi B; Narayanan TK; Potkin SG; Mukherjee J
J Nucl Med; 2005 Jan; 46(1):130-40. PubMed ID: 15632043
[TBL] [Abstract][Full Text] [Related]
33. Reduced striatal adenosine A2A receptor levels define a molecular subgroup in schizophrenia.
Villar-Menéndez I; Díaz-Sánchez S; Blanch M; Albasanz JL; Pereira-Veiga T; Monje A; Planchat LM; Ferrer I; Martín M; Barrachina M
J Psychiatr Res; 2014 Apr; 51():49-59. PubMed ID: 24433848
[TBL] [Abstract][Full Text] [Related]
34. Equilibrative nucleoside transporter ENT1 as a biomarker of Huntington disease.
Guitart X; Bonaventura J; Rea W; Orrú M; Cellai L; Dettori I; Pedata F; Brugarolas M; Cortés A; Casadó V; Chang CP; Narayanan M; Chern Y; Ferré S
Neurobiol Dis; 2016 Dec; 96():47-53. PubMed ID: 27567601
[TBL] [Abstract][Full Text] [Related]
35. Potential of an adenosine A2A receptor antagonist [11C]TMSX for myocardial imaging by positron emission tomography: a first human study.
Ishiwata K; Kawamura K; Kimura Y; Oda K; Ishii K
Ann Nucl Med; 2003 Sep; 17(6):457-62. PubMed ID: 14575379
[TBL] [Abstract][Full Text] [Related]
36. Iodination and radiolabeling of alpha-allocryptopine with iodine-125.
Wei Y; Wei X; Wang Y; Liu X; Chu T; Hu S; Wang X
Appl Radiat Isot; 2005 Jan; 62(1):55-62. PubMed ID: 15498685
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of 18F-CPFPX, a novel adenosine A1 receptor ligand: in vitro autoradiography and high-resolution small animal PET.
Bauer A; Holschbach MH; Cremer M; Weber S; Boy C; Shah NJ; Olsson RA; Halling H; Coenen HH; Zilles K
J Nucl Med; 2003 Oct; 44(10):1682-9. PubMed ID: 14530487
[TBL] [Abstract][Full Text] [Related]
38. Evaluation of carbon-11-labeled KF17837: a potential CNS adenosine A2a receptor ligand.
Noguchi J; Ishiwata K; Wakabayashi S; Nariai T; Shumiya S; Ishii S; Toyama H; Endo K; Suzuki F; Senda M
J Nucl Med; 1998 Mar; 39(3):498-503. PubMed ID: 9529299
[TBL] [Abstract][Full Text] [Related]
39. Synthesis of dendrimer-based biotin radiopharmaceuticals to enhance whole-body clearance.
Sato N; Park CW; Kim HS; Han ES; Wong KJ; Paik RS; Park LS; Yao Z; Carrasquillo JA; Paik CH
Nucl Med Biol; 2003 Aug; 30(6):617-25. PubMed ID: 12900287
[TBL] [Abstract][Full Text] [Related]
40. A covalent antagonist for the human adenosine A
Yang X; Dong G; Michiels TJM; Lenselink EB; Heitman L; Louvel J; IJzerman AP
Purinergic Signal; 2017 Jun; 13(2):191-201. PubMed ID: 27915383
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
